NCT01405118View on ClinicalTrials.gov

Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Metformin/CP-690,550

Single oral 500 mg dose of metformin on Days 1 and 4 and multiple oral 30 mg doses of CP-690,550 every 12 hours on Days 2-4.

Trial Locations (1)

B-1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT01405118 - Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers | Biotech Hunter | Biotech Hunter